This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Wahl, A. Articles by Windecker, S. Search for Related Content PubMed PubMed Citation Articles by Wahl, A. Articles by Windecker, S.

Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients

Andreas Wahl, MD^*, Ulrike Krumsdorf, MD, Bernhard Meier, MD^*, Horst Sievert, MD, Stephan Ostermayer, MD^,*, Kai Billinger, MD, Markus Schwerzmann, MD^*, Ulf Becker, MD^*, Christian Seiler, MD^*, Marcel Arnold, MD, Heinrich P. Mattle, MD and Stephan Windecker, MD

^* Cardiology
Neurology, University Hospital, Bern, Switzerland
Cardiovascular Center, Frankfurt, Germany

View larger version (18K): [in a new window]   Figure 1 Effect of transcatheter treatment of atrial septal aneurysm and patent foramen ovale on atrial septal mobility as assessed by paired transesophageal echocardiography.

View larger version (15K): [in a new window]   Figure 2 Freedom from the composite of recurrent transient ischemic attack, stroke, or peripheral embolism after transcatheter treatment for patients with atrial septal aneurysm and patent foramen ovale (ASA + PFO) and patients with PFO alone.

View larger version (15K): [in a new window]   Figure 3 Predictors for the composite of recurrent transient ischemic attack, stroke, or peripheral embolism after transcatheter treatment of atrial septal aneurysm and patent foramen ovale. CI = confidence interval; HR = hazard ratio.